MEDS
DataMeds AI, Inc.Company Information
- Company Name
- DataMeds AI, Inc.
- CIK
- CIK0002030763
- Category
- <br>Emerging growth company
- Ticker: Exchange
- MEDS: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 07 Trade & Services
- SIC
- 5122
- SIC Description
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- Ticker
- MEDS
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 51,842
- Shares outstanding
- 2,574,669
- Ownership
- 2.01%
Earnings Market Reaction
- Filing date
- 2026-08-17
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||
| Cash And Cash Equivalents At Carrying Value | 2 | 0 | 0 | 4 | 0 | 3 | 1 | ||||||
| Accounts Receivable Net Current | 1 | 1 | - | - | - | - | - | ||||||
| Inventory Net | 2 | 2 | 2 | 7 | 9 | 10 | 10 | ||||||
| Other Receivables Net Current | 0 | 0 | - | - | - | - | - | ||||||
| Prepaid Expense Current | 0 | - | - | 0 | 0 | 0 | 0 | ||||||
| Deferred Costs Current | - | - | - | - | - | - | 1 | ||||||
| Assets Current | 6 | 3 | 3 | 13 | 14 | 17 | 15 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Capitalized Computer Software Net | 2 | 2 | 2 | 2 | 2 | - | 2 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 1 | 2 | ||||||
| Goodwill | 14 | 14 | 14 | 16 | 16 | 16 | 16 | ||||||
| Other Intangible Assets Net | 10 | 10 | 10 | 18 | 19 | 20 | 21 | ||||||
| Notes And Loans Receivable Net Noncurrent | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | - | - | - | 1 | 1 | 1 | 1 | ||||||
| Deposits Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 33 | 30 | 30 | 53 | 54 | 58 | 57 | ||||||
Liabilities Current | |||||||||||||
| Equity Method Investments | - | - | - | - | - | 0 | 0 | ||||||
| Accrued Liabilities And Other Liabilities | 7 | 4 | 6 | 5 | 5 | 5 | 4 | ||||||
| Other Short Term Borrowings | - | - | - | 4 | - | - | - | ||||||
| Convertible Debt Current | 12 | 7 | - | - | - | - | - | ||||||
| Secured Debt Current | 7 | 9 | 11 | 12 | 13 | 18 | 12 | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities Current | 39 | 32 | 30 | 33 | 42 | 46 | 38 | ||||||
| Long Term Loans Payable | - | - | - | - | - | - | 0 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities | 52 | 45 | 43 | 46 | 53 | 54 | 51 | ||||||
Stockholders Equity | |||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 118 | 104 | 99 | 90 | 50 | 47 | 16 | ||||||
| Retained Earnings Accumulated Deficit | -137 | -119 | -111 | -83 | -49 | -42 | -10 | ||||||
| Stockholders Equity | -20 | -15 | -12 | 7 | 1 | 4 | 7 | ||||||
| Liabilities And Stockholders Equity | 33 | 30 | 30 | 53 | 54 | 58 | 57 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 500 | 500 | 500 | 500 | 500 | 500 | 500 | ||||||
| Common Stock Shares Issued | 3 | 2 | 2 | 2 | 1 | 1 | 1 | ||||||
| Shares Outstanding | 3 | 2 | 2 | 2 | 1 | 1 | 1 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialDataMeds AI, Inc. (MEDS) — SEC Financial Statements & Analysis
DataMeds AI, Inc. (MEDS) is a wholesale-drugs, proprietaries & druggists' sundries company, incorporated in DE. DataMeds AI, Inc. trades on Nasdaq as: MEDS. DataMeds AI, Inc. (MEDS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-17. Based on that filing, DataMeds AI, Inc. carries a market cap of $7.98M, a P/E ratio of -0.09x, a P/B ratio of -0.41x, a P/S ratio of 0.99x, an enterprise value of $24.73M, and an EV/EBITDA multiple of -0.36x. On profitability, it posts a gross margin of -90.64%, an operating margin of -875.75%, a net margin of -1100.30%, a Return on Equity (ROE) of 949.27%, a Return on Assets (ROA) of -202.97%, and a Return on Invested Capital (ROIC) of -691.64%. Per share, it reports EPS of $-34.29, diluted EPS of $-34.29, free cash flow per share of $-5.69, and a dividend per share of $0.00. On the balance sheet, it maintains a current ratio of 0.14x, a quick ratio of 0.09x, working capital of $-33.78M, a debt-to-equity ratio of -2.68x, a debt ratio of 1.6, an interest coverage ratio of -11.84x, free cash flow of $-14.66M (TTM), and net debt of $16.75M. Figures sourced from SEC EDGAR.
- Market Cap
- $7.98M
- P/E TTM
- -0.09x
- EPS TTM
- $-34.29
- P/B TTM
- -0.41x
- ROE TTM
- 949.27%
- ROA TTM
- -202.97%
- Debt To Equity
- -2.68x
- Free Cash Flow TTM
- $-14.66M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is DataMeds AI, Inc. in?
DataMeds AI, Inc. (MEDS) operates in the Wholesale-Drugs, Proprietaries & Druggists' Sundries industry.
What exchange does MEDS trade on?
DataMeds AI, Inc. (MEDS) trades on the Nasdaq.
Where is DataMeds AI, Inc. incorporated?
DataMeds AI, Inc. is incorporated in DE.
When was DataMeds AI, Inc. (MEDS)'s most recent SEC filing?
DataMeds AI, Inc. (MEDS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-17.
What is MEDS's market cap?
DataMeds AI, Inc. (MEDS) has a market capitalization of $7.98M as of 2026-06-30.
What is MEDS's EPS (earnings per share)?
DataMeds AI, Inc. (MEDS)'s trailing twelve month EPS is $-34.29 as of 2026-06-30.
What is MEDS's ROE (return on equity)?
DataMeds AI, Inc. (MEDS)'s trailing twelve month Return on Equity (ROE) is 949.27% as of 2026-06-30.
What is MEDS's ROA (return on assets)?
DataMeds AI, Inc. (MEDS)'s trailing twelve month Return on Assets (ROA) is -202.97% as of 2026-06-30.
What is MEDS's ROIC (return on invested capital)?
DataMeds AI, Inc. (MEDS)'s trailing twelve month Return on Invested Capital (ROIC) is -691.64% as of 2026-03-31.
What is MEDS's EV/EBITDA?
DataMeds AI, Inc. (MEDS)'s trailing twelve month EV/EBITDA is -0.36x as of 2026-06-30.